THOMAS TAYLOR to Treatment Outcome
This is a "connection" page, showing publications THOMAS TAYLOR has written about Treatment Outcome.
Connection Strength
0.055
-
Phase 2 trial of personal dendritic cell vaccines in newly diagnosed glioblastoma: 3-year follow-up and correlations with survival. Hum Vaccin Immunother. 2025 Dec; 21(1):2556591.
Score: 0.019
-
Subcutaneous sarilumab for the treatment of hospitalized patients with moderate to severe COVID19 disease: A pragmatic, embedded randomized clinical trial. PLoS One. 2022; 17(2):e0263591.
Score: 0.015
-
Design and Rationale for the Veterans Affairs "Cooperative Study Program 594 Comparative Effectiveness in Gout: Allopurinol vs. Febuxostat" Trial. Contemp Clin Trials. 2018 05; 68:102-108.
Score: 0.011
-
Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance. Lancet Infect Dis. 2015 Mar; 15(3):301-9.
Score: 0.009